DrugPatentWatch Database Preview
Ironwood Pharms Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for IRONWOOD PHARMS INC, and when can generic versions of IRONWOOD PHARMS INC drugs launch?
IRONWOOD PHARMS INC has two approved drugs.
There are nine US patents protecting IRONWOOD PHARMS INC drugs.
There are one hundred and seventy-seven patent family members on IRONWOOD PHARMS INC drugs in forty-one countries and twenty-six supplementary protection certificates in sixteen countries.
Summary for Ironwood Pharms Inc
| International Patents: | 177 |
| US Patents: | 9 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Ironwood Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 10,183,012 | Start Trial | Start Trial | ||||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 10,183,012 | Start Trial | Start Trial | ||||
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 8,003,681 | Start Trial | Y | Start Trial | |||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 8,283,369 | Start Trial | Start Trial | ||||
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 9,216,179 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ironwood Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2513390 | Start Trial |
| Tunisia | 2010000237 | Start Trial |
| Spain | 2380604 | Start Trial |
| European Patent Office | 1789039 | Start Trial |
| Australia | 2009289646 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ironwood Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2135608 | 16C0031 | France | Start Trial | PRODUCT NAME: LESINURAD; REGISTRATION NO/DATE: EU/1/15/1080 20160222 |
| 2582683 | 2019008 | Norway | Start Trial | PRODUCT NAME: ALLOPURINOL/LESINURAD ELLER ET FARMASOEYTISK AKSEPTERBART SALT ELLER SALTER DERAV; REG. NO/DATE: EU/1/18/1300/001-004 20180904 |
| 2135608 | PA2016024 | Lithuania | Start Trial | PRODUCT NAME: LESINURADAS; REGISTRATION NO/DATE: EU/1/15/1080 20160218 |
| 2135608 | C20160027 00203 | Estonia | Start Trial | PRODUCT NAME: LESINURAAD;REG NO/DATE: EU/1/15/1080 22.02.2016 |
| 2135608 | 93169 | Luxembourg | Start Trial | PRODUCT NAME: LESINURAD , OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION DATE: 20160222 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
